Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 69.2B | 66.3B | 71.1B | 74.5B |
| Cost of revenue | 56.5B | 59.4B | 59.9B | 62.6B |
| Gross profit | 12.7B | 6.8B | 11.1B | 11.9B |
| Operating expense | ||||
| Research & development | 185M | 331M | 294M | 263M |
| Selling general and admin | 2.8B | 3.2B | 3.1B | 3.1B |
| Other operating expenses | 210M | 860M | 305M | 496M |
| Operating income | 9.5B | 2.4B | 7.4B | 8.0B |
| Non operating interest income | ||||
| Income | 566M | 185M | 778M | 690M |
| Expense | 1.1B | 1.3B | 1.2B | 1.2B |
| Other income expense | — | — | — | — |
| Pretax income | 9.0B | 4.2B | 7.3B | 7.4B |
| Tax provision | 4.1B | 3.2B | 2.9B | 3.8B |
| Net income | 4.9B | 1.0B | 4.4B | 3.7B |
| Basic EPS | 1.6 | 0.3 | 1.4 | 1.1 |
| Diluted EPS | 1.6 | 0.3 | 1.4 | 1.1 |
| Basic average shares | 3.4B | 3.5B | 3.5B | 3.9B |
| Diluted average shares | 3.4B | 3.5B | 3.6B | 3.9B |
| EBITDA | 15.6B | 9.1B | 14.5B | 14.1B |
| Net income from continuing op. | 9.0B | 4.2B | 7.3B | 7.4B |
| Minority interests | -95M | -113M | -100M | -133M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |